BMS1P14

Across TCGA pan-cancer cohorts, BMS1P14 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated BMS1P14 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher BMS1P14 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated BMS1P14 expression acts as an unfavorable survival marker, although some lineages such as SKCM show a favorable association.

KIRC, THCA, and PCPG are the cancer types where BMS1P14 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Tertile	II,III,IV	0.361	0.690	.001	54	view →
THCA	OS	Tertile	III,IV	0.152	0.859	<.001	39	view →
PCPG	OS	Tertile	All	0.526	0.975	<.001	36	view →
UVM	OS	Tertile	All	0.248	0.769	.007	18	view →
ESCA	DFS	Tertile	All	0.148	0.673	.040	18	view →
COAD	DFS	Tertile	All	0.235	0.790	.010	18	view →
CHOL	OS	Tertile	All	0.155	0.725	.029	9	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	9	view →
HNSC	DFS	Tertile	II,III,IV	0.266	0.615	.037	9	view →
THYM	OS	Tertile	All	0.676	0.884	.028	6	view →
SKCM	OS	Tertile	II,III,IV	0.553	0.297	.031	3	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

BMS1P14–KIRC (DFS)

Open the KIRC breakdown →